Manipal Hospitals
| India | Turkey | Austria | |
| Tomotherapy | from $5,200 | from $12,000 | from $30,000 |
| Stereotaxic radiosurgery | from $5,200 | from $4,500 | from $17,000 |
| Radiotherapy for lung cancer | from $3,500 | from $4,000 | from $6,867 |
| Proton-beam therapy | from $25,000 | from $70,000 | from $80,000 |
| Pneumonectomy | from $8,800 | from $10,872 | from $50,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Lung cancer treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Lung cancer treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Lung cancer treatment journey.
Dr. Vadhiraja B. M. is a specialized radiologist at Manipal Hospitals, focusing on diagnostic imaging for lung cancer.
Dr. Raj Nagarkar has performed over 50,000 cancer surgeries with 30 years of experience of experience, specializing in breast and thoracic surgical oncology.
Over 15,000 successfully conducted cancer surgeries – Dr. Sundaram specializes in complex cases at Global Hospital Chennai.
Record-holder of trans-oral robotic surgeries in Asia – Prof. Dabas has performed over 8,000 head-neck and thoracic cancer surgeries.
Written by Mariia Mytrofankina
Primary lung cancer treatments in India include minimally invasive surgery, precision radiation, and personalized medical oncology. Leading JCI-accredited centers in Delhi and Mumbai utilize advanced technologies like the da Vinci robotic system and CyberKnife. These facilities offer survival rates comparable to international clinical standards.
Bookimed Expert Insight: Clinical volume often correlates with surgical precision in India. Prof. Surender Dabas at BLK Super Speciality Hospital holds a record for trans-oral robotic surgeries. Similarly, Dr. Raj Nagarkar at HCG Manavata has performed over 50,000 cancer surgeries. Choosing such high-volume specialists can significantly improve outcomes for complex thoracic cases.
Patient Consensus: Patients emphasize the importance of getting genetic biomarker testing immediately. They note that the coordination support from teams like those at BLK Super Speciality Hospital is essential for managing 24-hour needs during treatment.
India is a safe, high-authority destination for international patients. Its healthcare system features over 45 JCI-accredited hospitals. Specialized centers like Apollo and Manipal follow global sterilization and infection protocols. Most specialists are trained in the US or UK. Government-backed e-medical visas ensure legal, organized travel.
Bookimed Expert Insight: Data shows a massive experience gap in Indian oncology. Dr. Surender Dabas at BLK Hospital holds the Asian record for robotic thoracic surgeries. While many countries offer robotic options, Indian surgeons often have 4-5 times the procedural volume. This high repetition contributes to 90% or higher success rates in complex lung cancer cases.
Patient Consensus: Patients emphasize sticking to major hubs like Delhi or Chennai for the best care. Many note that having a dedicated coordinator helps navigate local logistics easily.
Success rates for lung cancer treatment in India reach 70% to 90% for early-stage cases. While the national 5-year survival rate is 9.6% due to late diagnoses, modern targeted therapies for EGFR or ALK mutations show response rates of 60% to 70% in advanced stages.
Bookimed Expert Insight: India is a global leader in high-volume thoracic surgery. Dr. Raj Nagarkar at HCG Manavata has performed over 50,000 cancer surgeries. Clinics like Global Hospital Chennai were the first in India to perform minimally invasive lung transplants. This massive clinical experience often results in better precision for complex tumor removals.
Patient Consensus: Patients emphasize the need for immediate genomic testing at major centers in Delhi or Mumbai. They note that catching the right mutation early can unlock more effective treatment options than standard chemotherapy.
Immunotherapy and targeted therapy are widely accessible at major Indian oncology centers for lung cancer. Facilities like Apollo Hospital and Manipal Hospitals utilize biomarker testing to match patients with drugs like Keytruda. These advanced protocols are now standard for non-small cell lung cancer cases.
Bookimed Expert Insight: Patient data shows that choosing a facility with research-heavy backgrounds often provides faster access to the newest therapies. For example, Dr. Raj Nagarkar at HCG Manavata has participated in over 200 clinical trials. This clinical involvement often helps patients access next-generation protocols before they become widely available in smaller regional hospitals.
Patient Consensus: Patients note that getting biomarker testing done early in a major city center is essential. They also highlight that coordinators help manage the logistics of 24-hour communication when traveling from abroad for care.
India hosts high-volume oncology centers like Medanta and Apollo Hospital Indraprastha. These facilities utilize robotic surgery and proton therapy for lung cancer. Accredited by JCI and NABH, these hospitals serve over 1,000,000 international patients annually with advanced thoracic surgical programs.
Bookimed Expert Insight: While many seek major brands, Global Hospital Chennai stands out for specialized lung care. It is a national leader in complex pulmonology and performed the first minimally invasive lung transplant in India. This specific surgical expertise often translates to better recovery outcomes for thoracic oncology patients compared to general cancer centers.
Patient Consensus: Patients emphasize vetting specific thoracic surgeons like Dr. Surender Dabas rather than just hospital names. They also note that private hospital costs are significantly higher than government centers, but offer much faster access to treatment.
India offers highly affordable lung cancer treatment through government-funded schemes and high-volume charitable networks. Patients can access low-cost care at prestigious institutions like Manipal Hospitals or Apollo Hospital Indraprastha. These facilities combine advanced technology with cost structures designed for diverse income levels.
Bookimed Expert Insight: Patients can find specialized care at clinics like HCG Manavata, where Dr. Shruti Kate manages complex lung cancer cases. This center is notable because it uses the IBM Watson program to select the most effective treatment paths. This technology helps ensure patients receive the correct protocol immediately, which can reduce overall costs by avoiding ineffective therapies.
Patient Consensus: Patients note it is vital to check for government hospital eligibility early to manage timelines. They also suggest requesting prescriptions using generic drug names to significantly lower medication expenses.
Indian medical centres offer a full range of lung cancer treatments. These include minimally invasive robotic surgery, immunotherapy, and high-precision radiation. Specialists at JCI-accredited hubs like Apollo Hospital Indraprastha use multidisciplinary teams. They design plans based on the cancer stage and molecular type.
Bookimed Expert Insight: Indian oncology centres often offer decision-support technologies like IBM Watson. Hospitals such as Manipal use this to analyse clinical data against global literature. This helps doctors select the most effective chemotherapy or targeted drug protocols.
Patient Consensus: Patients note the importance of completing molecular biomarker testing before starting therapy in India. They frequently highlight the 24-hour support from coordinators. They suggest confirming the full cost of follow-up scans and pathology before beginning treatment.
Indian oncology centres offer biomarker and genetic testing for lung cancer patients. Leading facilities use Next-Generation Sequencing (NGS) and liquid biopsies to identify targets like EGFR, ALK, and PD-L1. These tests guide personalised immunotherapy and targeted treatments at accredited laboratories.
Bookimed Expert Insight: Indian cancer centres specialise in high-volume genomic data. HCG Manavata Cancer Centre has participated in over 200 clinical trials. Dr Shaunak Valame there focuses on the molecular basis of cancer and targeted therapies. This research depth means patients often access new testing protocols early.
Patient Consensus: Patients note that larger Indian centres integrate molecular testing into treatment plans. They recommend checking if the biopsy sample is large enough for full profiling. Do this before starting immunotherapy.
Indian medical facilities manage Stage 4 lung cancer using international protocols focused on extending survival. JCI-accredited centres provide systemic therapies like immunotherapy and targeted therapy based on molecular profiling. Specialists use technologies such as CyberKnife and robotic systems to treat metastases and control symptoms.
Bookimed Expert Insight: Indian oncology focuses heavily on volume-based expertise. Dr Raj Nagarkar at HCG Manavata has performed over 50,000 cancer surgeries. This high case frequency helps Indian specialists manage complex Stage 4 complications. Many centres also use IBM Watson software to support treatment decisions with global data.
Patient Consensus: Patients note that large private hospitals in Indian cities provide coordinated care. These facilities house oncology, pathology, and palliative services in one building. Those travelling to clinics like BLK Super Speciality praise the constant support from coordinators.
Lung cancer success rates in India vary by stage. For tumours under 2 cm detected early, 5-year survival reaches 80% to 90%. Centres like Apollo Hospital Indraprastha and Manipal Hospitals provide JCI-accredited care. They report a 71.75% disease control rate during first-line therapy.
Bookimed Expert Insight: Indian oncology is defined by massive case volumes and specialised surgical expertise. Dr Surender Dabas at BLK Super Speciality Hospital has performed 8,000 procedures. Dr Raja Sundaram at Global Hospital Chennai has handled over 15,000 surgeries. Surgeons here often manage complex thoracic cases more frequently than specialists in smaller markets.
Patient Consensus: Patients find that outcomes depend heavily on molecular testing and early surgical intervention. They note that high-volume centres provide faster access to second opinions. Multidisciplinary teams are also vital for managing advanced cases.
Mumbai, Delhi NCR, Chennai, and Bengaluru are the main hubs for lung cancer treatment in India. These cities house JCI-accredited facilities and specialise in medical interventions. Patients access proton beam therapy, robotic-assisted thoracic surgery, and complex genomic profiling for targeted immunotherapy.
Bookimed Expert Insight: Surgical volume is a critical quality indicator in Indian oncology centres. Dr Raj Nagarkar and Dr Raja Sundaram have each performed over 15,000 to 50,000 cancer surgeries. This immense experience often leads to more refined techniques in thoracic resections.
Patient Consensus: Patients often praise the 24-hour support from coordinators and the efficient medical teams in India. They note that receiving results and treatment plans quickly is a significant benefit.